Grand Hyatt Shanghai New Growth Models For China
|
|
- Egbert Lawson
- 5 years ago
- Views:
Transcription
1 Grand Hyatt Shanghai New Growth Models For China At the PharmAsia Summit Shanghai, Elsevier and BayHelix will focus on new R&D and commercial models in a rapidly changing China. Given demographic changes and China's massive health care reforms, opportunities abound - but so do potential pitfalls. Tapping the unmet medical need present in China provides Pharma with one of its few growth bright spots. But achieving this growth will require new models and flexibility: smaller cities are now growing faster than Tier I cities presenting logistical challenges; off-patent medications are under severe pricing pressure, which could limit the widespread uptake of branded generics. While support for biopharma innovation is a major government goal, so is curbing healthcare inflation. How can Pharmas collaborate and thrive in this environment? At the PharmAsia Summit, top industry leaders from China and the West will discuss new growth models for China via a series of case studies, panels and keynotes. To kick-off the Summit, we will release our 2 nd annual PharmAsia Summit Report, an in-depth analysis of trends critical to biopharmaceutical development and commercialization in the China market, authored by our knowledge partner, McKinsey & Co. Inc. The agenda for the PharmAsia Summit is developed by an organizing committee chaired by Steve Yang, PhD, VP, Head of Asia and Emerging Markets imed, AstraZeneca PLC. Presented By Knowledge Partner
2 Agenda to Date (subject to change) Simultaneous translation will be provided throughout the conference 12:00-12:50 Registration 12:50PM Welcome and Opening Remarks 1:00-2:00PM Roundtable 1 2:00-2:30PM 2:30-3:30PM 3:30-4:00PM 4:00-5:00PM Networking Break Therapeutic Spotlight: Opportunities and Challenges in China s Oncology Market Sponsored by Kantar Health Networking Break Doing Business Development in China Today: An Analysis of Top Deal Structures Sponsored by Navigant Paul Zhang Managing Director, Life Sciences Navigant Sundeep Lal, PhD VP, Strategy, Business Development & Business Model Innovation Medtronic 5:00-6:15PM Opening Plenary Session: Presentation of the 2013 PharmAsia Summit China Report In our opening plenary, McKinsey & Co., Elsevier and BayHelix will discuss findings from our exclusive report on how to enable innovation and drive growth in China in an environment of intensifying cost pressure. Conference attendees will receive a complimentary copy of the report. Franck LeDeu Leader of Greater China Healthcare Practice McKinsey & Co. Inc. Jimmy Zhang, PhD Greater China Lead, Licensing, Acquisitions, and External Research Merck & Co. Inc.
3 6:15-8:00PM Welcome Reception 7:30-8:30AM Breakfast Networking & Facilitated Discussions Want another chance to interact with other attendees and speakers? These breakfast discussions are an excellent way to discuss and learn about industry challenges, and each will be led by a China pharma expert. Each table is limited to 10 people; first come, first serve. Sign-up sheets will be available onsite. Choose to participate in one of several facilitated discussions on key topics facing the industry. 1. The Commercial Challenge 2. The R&D Challenge, facilitated by Franck LeDeu, McKinsey & Co. 3. The Regulatory Challenge 4. The Payer Challenge 5. The Funding Challenge 6. The BD Challenge 8:30-8:45AM Welcome, Elsevier and Bay Helix Opening Remarks & Meeting Overview Franck LeDeu Leader of Greater China Healthcare Practice McKinsey & Co. Inc. 8:45 9:30AM KEYNOTE ADDRESS Fueling Roche s Growth: The Importance of the Asia Pacific Region Luke Miels Regional Head, Asia Pacific Roche Singapore Pte Ltd.
4 9:30-10:45AM KEYNOTE PANEL Defining A China-based Innovation Strategy: Should Early Stage R&D Be A Priority? The question was never if China would produce innovative products but when and what kind. As the market in China evolves, the notion of innovation is changing. Skeptics wonder if R&D groups have the internal capabilities required to translate early stage science into novel pharmaceutical products and whether the Chinese government will pay for them if they do. Instead of trying to create a second-wave of Eastern-researched blockbusters, why not focus on health care services and fast-follower molecules, tailored to the huge unmet medical needs that exist in the country today? In this session, heads of China R&D from multinationals and domestic companies discuss the R&D opportunities that make the most sense now. Steve Yang, PhD VP, Head of Asia and Emerging Markets imed AstraZeneca Liangshang Zhang, PhD President of Global R&D Jiangsu Hengrui Medicine James Garner, MD Vice President and Global Manager Takeda Global Research and Development Center (Asia) Henry Sun, PhD President and CEO Tasly Pharmaceuticals Inc. 10:45 11:15AM Networking Break
5 11:15-12:15PM The New Goldrush: Biologics Investment in China Improving infrastructure, government funding, and local demand for products to treat complex diseases are driving private equity investment in China s nascent biologics sector. But the dearth of manufacturing capacity, the challenging regulatory environment, weak IP protection, and still developing R&D capabilities cause some to wonder just how golden is China s biologics opportunity? Panel participants will discuss how best to leverage China s growing biologics capabilities and resources while minimizing the execution challenges. Racho Jordanov President and CEO JHL Biotech Michael Yu, PhD President and CEO Innovent Biologics Inc. Jeremy Caudill Global Vice President Business Development Samsung Biologics
6 12:15-1:15PM Regulatory Insight: Strategies to Accelerate the Time To Market SFDA s so-called Green Channel allows drug sponsors to formally consult with the regulatory body in an effort to speed up the notoriously slow China drug approvals process. Now SFDA, and its successor CFDA, appears ready to take the channel one step further, proposing a parallel system that simultaneously reviews investigational new drug applications and ethical committee evaluations. In this panel discussion we review not just the current workings of the Green Channel, but other strategies, including joint venture structures and Asia-based clinical trial designs, which multi-nationals can use to accelerate the development time line to launch products more rapidly in China. Ling Su, PhD (moderator) Strategic Advisor, Life Sciences Sidley Austin LLP George Yeh President Taiwan Liposome Company Ltd. Benny Li, PhD Vice President and Head of Development Takeda Pharmaceuticals China Ruilin Song Executive President SINO-PhIRDA 1:15-2:30PM Lunch + Elsevier-Bay Helix Awards Ceremony 1. R&D Achievement Of The Year 2. Alliance Of The Year 3. Commercial Achievement Of The Year 4. R&D Leadership Award
7 2:30-3:30PM Debate: What s Needed Now To Support Early Stage China Biotechs Perhaps the biggest challenge facing early stage biotechs in China is the dearth of private equity to finance them. This capital dry spell has VCs and execs worried that the U.S. s famed Valley of Death is rapidly sickening China-based biotechs as well. Skeptics scoff, likening such talk to Chicken Little s claim that the sky is falling. They argue the lack of available financing is explained by a simpler reason: there just aren t many new opportunities that are scientifically compelling and can deliver the needed ROI. In this hour-long session, top executives will debate strategies that are best suited to move early stage biotechs to the growth phase of their life cycles. Kewen Jin, PhD (moderator) Managing Director Nimbus Innoworks John Oyler Founder and CEO BeiGene Ltd. Jonathan Wang, PhD Senior Managing Director OrbiMed Samantha Du, PhD Managing Director Sequoia Capital China Carl Firth, PhD CEO Aslan Pharmaceuticals 3:30-4:15PM KEYNOTE ADDRESS At the Intersection of Drug Distribution and Health Care Policy: The View from Cardinal China Eric Zwisler President, China Cardinal Health China 4:15-4:30PM Networking Break
8 4:30-5:45PM BD in China: Why Now Is The Time To Partner With Domestics (PAS/PSA Showcase Panel) Government reform initiatives, pricing pressures, and slowing growth in Tier 1 cities make it difficult for multinationals to sustain their current China growth rates organically. To succeed, MNCs have sought alliances with Chinese domestic pharmas to access their commercial channels and are changing their approaches to partnering in the region. At the same time China-based entities are making inroads in their quest for access to innovative molecules and platforms, including presenting internally developed assets to US regulators. In this panel discussion, you ll hear from experts at multinationals and domestic outfits about deal-making in today s China, not only with each other, but with parties seeking to access new capabilities across the value chain. What kinds of alliances are today s hottest China-based deal makers most interested in pursuing? What deal structures work best to promote a given strategy? Debra Yu, MD (moderator) Managing Director Labrador Advisors Jimmy Zhang, PhD Greater China Lead, Licensing, Acquisitions & External Research, WW Licensing & Acquisitions Merck & Co., Inc. Jun Bao, PhD Senior Vice President and Chief Business Officer Shenogen Pharma Group Ltd. Sophie Kornowski-Bonnet Head of Roche Partnering Roche Sam Hua Jiang Vice President (International Business) Luye Pharma Group Philip Fang Business Development Director China Resources Pharmaceutical Group Ltd. 6:00PM Cocktail Reception
9 7:30-8:30AM 8:30-8:45AM Breakfast Networking Welcome Back and Recap Franck LeDeu Leader of Greater China Healthcare Practice McKinsey & Co. Inc. 8:45-9:30AM KEYNOTE ADDRESS 9:30-10:30AM Sanofi s APAC Strategy: The Strategic Importance of China Jean-Luc Lowinski, PhD SVP Asia Region Sanofi Bridging the Affordability Gap: Improving Market Access To High-Priced Therapeutics As China s middle class hungers for access to high-priced medicines designed to treat severe diseases like cancer, multinationals can t rely completely on traditional mechanisms like patient assistance programs. One solution: work with local insurers to design supplemental commercial insurance that patients can tap if they need medicines that aren t listed on the National Drug Reimbursement List. It s a strategy that s been highly successful for Roche, which saw its China-based product sales skyrocket 27% in Alternatively, there s the opportunity to partner with wealthier provinces to reimburse therapies in high priority diseases, particularly liver, lung, and gastric cancer. In exchange for patient volume, biopharmas would provide provincial governments with significant rebates and patient assistance. This panel highlights innovative experiments designed to bridge China s affordability gap. Paul Zhang (moderator) Managing Director Navigant Harald Sprenger Director Access Asia-Pacific Roche Pharmaceuticals Howard Gough Managing Director, CGHB, Asia Pacific CIGNA
10 10:30-11:00AM 11:00-12:15PM Networking Break Pricing Pressure: Winning Strategies In An Era Of Cost Containment There s always been an art to pricing pharmaceutical products; in China, however, this artistry reaches new heights. A national pricing scheme sets maximum retail prices for reimbursed drugs, and then mandates periodic cuts. At the provincial level, China s 31 provinces have competitive tenders, each with their own rules to determine the value of a drug. Inter-provincial reference pricing and hospital protocols that require formulary listing or cap annual reimbursement further complicate the process. To top it off, China recently expanded its Essential Drug List (EDL) to cover more than 500 new products, including off-patent China blockbusters. Against this backdrop, pharma companies are testing new strategies to thrive in an era of increasing cost pressures. Franck Le Deu (moderator) Leader of Greater China Healthcare Practice McKinsey & Co. Richard Yeh Research analyst Citigroup Ingrid Zhang Head of Specialty Business Novartis Pharma Greater China Yan Che Strategy Management Bayer Guohong Shan General Manager, Specialty Care Business Unit Pfizer 12:15-1:00PM In Depth: Understanding the Beta Pharma/Amgen Joint Venture James Li, MD (Invited) Vice President and General Manager, Greater China Amgen
11 1:00-3:00PM KEYNOTE PANEL Big Pharma GMs Present A View From the Top (Includes 30 minutes for buffet lunch) This panel is designed to sum up the themes discussed the previous two days, bringing together three top China biopharma GMs, who will each provide an overview of their incountry strategies. In the moderated discussion that follows, we ll explore commonalities and differences in those strategies and ask participants how priorities are changing to meet the evolving needs of a rapidly changing China. Tamra Sami (moderator) Managing Editor, PharmAsia News Elsevier Business Intelligence Thad Huston President Xian Janssen Pharmaceutical Ltd. Johnson & Johnson Jean-Christophe Pointeau President Bristol-Myers Squibb China & Sino-American Shanghai Squibb (SASS) David Snow President, China and Hong Kong AstraZeneca 3:00PM Closing Comments: See You in 2014!
12 Organizing Committee Chairman Steve Yang, PhD VP, Head of Asia and Emerging Markets imed AstraZeneca Tony Zhang, PhD VP, External R&D, Asia Eli Lilly Jun Bao, PhD Director, WW Business Development Head of China GlaxoSmithKline Darren Ji, PhD Global Head of Partnering, Asia and Emerging Markets Roche George Baeder SVP Asia Pacific Consulting & China Commercial Quintiles Debra Yu, MD Managing Director Labrador Advisors Kewen Jin, PhD Principal Nimbus Innoworks Jay Dong General Manager Asia Pacific Cell Signal Technology Jimmy Zhang, PhD Greater China Lead, Licensing, Acquisitions and External Research WW Licensing and Acquisitions Merck and Co., Inc. Yun He Professor, Innovative Drug Research Center Chongqing University Franck Le Deu Partner, Leader of McKinsey Greater China Healthcare Practice McKinsey & Company Joshua Berlin Executive Editor & Director of Business Development Elsevier Business Intelligence Tamra Sami Managing Editor, PharmAsia News Elsevier Business Intelligence Daniel Poppy Associate Managing Bureau Editor, PharmAsia News Elsevier Business Intelligence Dai Jialing China Bureau Chief, PharmAsia News FDC Reports/ Elsevier Business Intelligence Brian Yang Senior Writer PharmAsia News
Accelerating Pharmaceutical Growth through Open Innovation and Global Collaborations
Sino American Pharmaceutical Professionals Association 美中醫藥開發協會 Accelerating Pharmaceutical Growth through Open Innovation and Global Collaborations August 3-4, 2012 New Jersey, USA PRELIMINARY PROGRAM
More informationCross-Border R&D in China Understanding the Regulatory Challenges
1 2 Cross-Border R&D in China Understanding the Regulatory Challenges 1 Panelists Moderator: Paul A. Stewart, Silicon Valley Office Managing Partner, Foley & Lardner LLP Speakers: David Rosen, Partner,
More informationCASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. Your Strategic Drug Development Partner in China NASDAQ: CASI WWW.CASIPHARMACEUTIALS.COM Forward Looking Statements This presentation contains forward-looking statements within
More informationCrack the Code: Demystify the Success Factors for Career Development
Crack the Code: Demystify the Success Factors for Career Development March 1, 2014, Saturday Rutgers University 675 Hoes Lane West Piscataway, NJ 08854 Sino-American Pharmaceutical Professionals Association
More informationState of Licensing 2011 Update
State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-
More informationNVESTOR. 1,400+ Attendees. 2,700+ Partnering Meetings. 768 Companies. 700 Registered Investors. 158 Company Presentations
February 11-12, 2019 New York Marriott Marquis Now in its 21 st year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and
More informationFeature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in
Feature Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia Based on our long-term strategic vision toward 2020, our goal is to become #1 in Asia in terms of our
More informationWOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview
Strategic Advisory Services 2018 Firm Overview Our Foundational Principles Strategic Advice for Biopharmaceutical, Medical Technology and Life Science sectors A Focus on Strategic Thinking in the Context
More informationAssociate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive
Job Title Alliance Lead Analytics Specialist Associate Director Associate Director Diagnostics Partnering Associate Director Business Development Associate Director Application Architecture Associate Manager
More informationExclusive. InterContinental Shanghai, Expo Pudong New District, Shanghai Thursday October 27, 2016
InterContinental Shanghai, Expo Pudong New District, Shanghai Thursday October 27, 2016 Exclusive Asia Cicor Innovation Insights Symposium Opportunities and Challenges for Medical Devices companies Asia
More informationPerspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond
Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,
More informationReinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D
Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &
More informationTHE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID
More informationThe Cannabis Industry Growth Opportunities for Professionals, Operators and Investors
The Cannabis Industry Growth Opportunities for Professionals, Operators and Investors Conference Program Tuesday October 17, 2017 Hilton Boston Dedham TABLE OF CONTENTS SECTION PAGE OUR PARTNERS Thank
More informationASIFMA Annual Conference 2014
ASIFMA Annual Conference 2014 A large-scale, industry-wide event providing a unique opportunity for global and regional policy makers, high-level regulators, senior industry representatives from both sell-side
More informationPHARMA S NEW PHASE. Technological integrators play as crucial a role as banks in Big Pharma s latest M&A boom. They re back.
Renew-New PHARMA S NEW PHASE Technological integrators play as crucial a role as banks in Big Pharma s latest M&A boom They re back. Mergers & acquisitions, that is and in a big way. Wall Street and City
More information2 Decades On: Perspectives from the Asian Financial Crisis: New Risks and Opportunities Take Shape.
AGENDA 8:30AM 9:00AM 9:05AM REGISTRATION & BREAKFAST OPENING REMARKS KEYNOTE ADDRESS Asia Pacific 20 Years After the Crisis Causes and lessons learned (or not) Is Asia still the fastest growing region
More informationFDA Centers of Excellence in Regulatory and Information Sciences
FDA Centers of Excellence in Regulatory and Information Sciences February 26, 2010 Dale Nordenberg, MD novasano HEALTH AND SCIEN Discussion Topics Drivers for evolution in regulatory science Trends in
More informationFuture of Healthcare ACCESS Health Shanghai June Mentor Networking
Our vision is that all people, no matter where they live, have a right to access high quality, affordable healthcare Future of Healthcare ACCESS Health Shanghai June Mentor Networking Room 303, Building
More informationHealth 2.0 Asia 2016 Korea-China Program. Korea Program
Health 2.0 Asia 2016 Korea-China Program Korea Program Sunday, November 6, in Korea Agenda Pre-Conference: Global Alliance Special Session 18:00~20:00 (2 hrs) Before the main event begins, we have Global
More informationa Part of BioTaiwan 2015 Events July 22-23, F, Bldg. A, CTBC Financial Park Organized by Taiwan Bio Industry Organization
a Part of BioTaiwan 2015 Events July 22-23, 2015 3F, Bldg. A, CTBC Financial Park www.bio-taiwan.com Organized by Taiwan Bio Industry Organization BioBusiness Asia Conference 2015 Day 1 Tentative Agenda
More informationFinal Pitch Competition PROGRAM GUIDE. Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV
Final Pitch Competition PROGRAM GUIDE Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV #HITVenture #HIMSS16 1 Presented by: WEDNESDAY, MARCH
More informationHarry Smorenberg Founder & Chairman, Global Payment Summit /
The 3rd annual Global Payment Summit (GPS) in Singapore is a leading forum where key thought leaders, experts and practitioners in the payment and transaction arena meet and discuss the innovation agenda.
More informationVenture Capital Search Highlights
Venture Capital Venture funding continued at the strongest pace witnessed over the past decade in 2016, and recruiting the future leaders of the industry s emerging growth companies has never been more
More informationPwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update
PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease
More informationMidwest Regional Forum. Work Smarter Not Harder Leveraging Prior Knowledge to Accelerate CMC Programs
Midwest Regional Forum Work Smarter Not Harder Leveraging Prior Knowledge to Accelerate CMC Programs Tuesday, October 23, 2018 Loews Chicago O Hare Hotel Rosemont, IL Meeting Co-chairs: Sarah Demmon, Eli
More informationMedicines Manufacturing in the UK 2017
Medicines Manufacturing in the UK 2017 Moderator: Magda Papadaki, PhD Head of Manufacturing Innovation The Association of the British Pharmaceutical Industry Medicines Manufacturing Industry Partnership
More informationA Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data
External Review of Pan-Canadian Health Organizations Thank you for the opportunity to provide input for your ongoing review of the Pan- Canadian Health Organizations (PCHOs). This submission is made on
More information2018 ADSO Summit The Gold Standard DSO Event of the Year
2018 ADSO Summit The Gold Standard DSO Event of the Year Join us April 18-20, 2018 at the JW Marriott Austin in Austin, Texas for the 2018 ADSO Summit! This event s attendance has grown exponentially over
More informationVirtual Clinical Trials: Challenges and Opportunities
Virtual Clinical Trials: Challenges and Opportunities November 28 29, 2018 National Academy of Sciences Building, Lecture Room 2101 Constitution Ave. NW, Washington, DC 20418 Background: The cost of bringing
More informationPlease join us as a committed sponsor to make the NC CEO Forum as spectacular, educational and enjoyable as ever. We can t do this without you!
INVITATION TO SPONSOR Currently in its eighth year, the North Carolina CEO Forum is an invitation-only leadership event that welcomes 400 senior business, government and non-profit leaders who are committed
More informationPANEL DISCUSSION & ROUNDTABLES
LIFE SCIENCES & HEALTH CARE EVENT Road to commercialization - Challenges, Opportunities & Successes that lie ahead in the Life Sciences and Healthcare Sectors Life Sciences and Healthcare is one of the
More informationData-Driven Evaluation: The Key to Developing Successful Pharma Partnerships
R&D Solutions for PHARMA & LIFE SCIENCES DRUG DISCOVERY & DEVELOPMENT Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships Summary For pharmaceutical companies to succeed, it is
More informationInclusion Women at the Forefront of STEM
Innovation and Inclusion Women at the Forefront of STEM Hosted by the Association for Women in Science SPONSORSHIP Innovation and Inclusion: Women at the Forefront of STEM The Association for Women in
More informationMixed Signals: Understanding the Outlook for Pharma R&D Spending Through
Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through 2015 www.pharmsource.com 1 Presenters Jim Miller President and Founder, PharmSource Saul Richmond, PhD Director of Market Intelligence,
More informationInnovation and the Changing Practice of Medicine
Innovation and the Changing Practice of Medicine Japan Medical Innovation Symposium David Epstein, Division Head Novartis Pharmaceuticals Tokyo, August 18, 2015 Agenda The Case for Innovation How Novartis
More informationAccelerating Pharmaceutical Growth through Open Innovation and Global Collaborations
Sino-American Pharmaceutical Professionals Association 美中醫藥開發協會 Accelerating Pharmaceutical Growth through Open Innovation and Global Collaborations August 3-4, 2012 New Jersey, USA PRELIMINARY PROGRAM
More informationCONFE R E NC E AG E NDA
CONFE R E NC E AG E NDA A DVA MED PAYMENT POL ICY As the reimbursement and coverage landscapes for the medical technology industry are continuously changing, s 4th Annual Payment Policy Conference will
More informationCONFERENCE AGENDA. Empowering Your Clinical Trial Operations Through Digital Innovation. 5 6 December 2018, Grand Copthorne Waterfront, Singapore
CONFERENCE AGENDA Empowering Your Clinical Trial Operations Through Digital Innovation 5 6 December 2018, Grand Copthorne Waterfront, Singapore Researched & Developed by CONFERENCE DAY ONE: WEDNESDAY,
More informationBerlin Summit, Hotel Adlon Kempinski, April 26-27, 2012
Berlin Summit, Hotel Adlon Kempinski, April 26-27, 2012 Regulators + Payors + Providers + Pharma + Medtech + Investors presented by: roman rittweger advisors in healthcare Welcome to Innovations & Investments
More informationBREAKTHROUGH CONVENTION SUMMARY JUNE SAN DIEGO CONVENTION.BIO.ORG #BIO2017
BREAKTHROUGH CONVENTION SUMMARY JUNE 19-22 SAN DIEGO CONVENTION.BIO.ORG #BIO BIO BY THE NUMBERS FEATURING SEVERAL THEMATIC EXHIBITS 16,123 ATTENDEES 74 48 COUNTRIES STATES 18,000 MORE THAN EXHIBITORS 41,400
More information2018 IIF ANNUAL MEMBERSHIP MEETING
2018 IIF ANNUAL MEMBERSHIP MEETING October 12-13, 2018 Grand Hyatt, Bali, Indonesia PRELIMINARY AGENDA *Subject to change* FRIDAY, OCTOBER 12 8:00 am 9:00 am REGISTRATION AND CONTINENTAL BREAKFAST 9:00
More informationVALUE BASED HEALTHCARE. 20 th SEPTEMBER 2018 KINGDOM OF SAUDI ARABIA Venue : Riyadh Marriott Hotel, Riyadh, KSA
VALUE BASED HEALTHCARE 20 th SEPTEMBER 2018 KINGDOM OF SAUDI ARABIA Venue : Riyadh Marriott Hotel, Riyadh, KSA www.valuebasedhealth.org JOIN US FOR THE VALUE-BASED CARE SUMMIT, KSA TO HEAR FROM THE POLICY
More informationBIOPHARMACEUTICAL SECTOR TRAINING SESSION (DAY ONE) 1 SEPTEMBER 2014
APEC Business Ethics for SMEs Forum: Promoting Ethical Environments in the Medical Device & Biopharmaceutical Sectors Sofitel Nanjing Zhongshan Nanjing, China 1-3 September 2014 BIOPHARMACEUTICAL SECTOR
More informationTRANSLATIONAL SCIENCE
TRANSLATIONAL SCIENCE A Discussion of Best Practices and Unique Models Wednesday January 31, 2018 at The NYSCF Research Institute HRA TRI-STATE REGIONAL MEETING 31 Wednesday January, 2018 AGENDA 8:30 AM
More informationTuesday, 6 November 2018
Tuesday, 6 November 2018 08:00-09:00 Registration and Coffee 09:00-09:15 Opening Ceremony 09:15-09:30 Welcome Addresses 09:30-09:45 Awards Ceremony 09:45-10:45 Private Exhibition Tour 09:45-10:45 Keynote
More informationAqua Pharmaceuticals, LLC
Aqua Pharmaceuticals, LLC Corporate Presentation June 2011 AQUA PHARMACEUTICALS, LLC 1 Company Overview Specialty dermatology pharmaceutical company currently focusing on acquiring, developing and marketing
More informationGLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS
GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
More informationAmerican Chamber of Commerce in Taipei
American Chamber of Commerce in Taipei Presented by Andrea Wu President, AmCham Taipei 2012 March 23 Taking the Pulse of Taiwan Business Mission Rule of Law "AmCham fosters the development of investment
More information4:30-5:30 pm An Update on Chinese Domestic Politics: Implications for American Business
Tuesday, April 26 2:30-3:00 pm Registration 3:00-3:15 pm Introductory Remarks Tami Overby, Senior Vice President for Asia, U.S. Chamber of Commerce James Zimmerman, Chairman, American Chamber of Commerce
More informationWIRED BIOSCIENCE INSTITUTE. February 5-6, 2008 Winston Salem, North Carolina
Day 1: February 5, 2008 WIRED BIOSCIENCE INSTITUTE February 5-6, 2008 Winston Salem, North Carolina 7:30-8:30am 8:30-9:00am 9:00-10:00am 10:00-10:15am 10:15-11:30am Registration Welcome, Opening Remarks,
More informationOrganized by: Main Sponsors: Co-sponsors:
THE 2005 INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE / STANFORD PROJECT ON REGIONS OF INNOVATION AND ENTREPRENEURSHIP (ITRI-SPRIE) CONFERENCE The Greater China Capital Market for Innovation and Entrepreneurship
More informationNASDAQ: CASI Partnering Presentation
NASDAQ: CASI Partnering Presentation Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to
More informationBiotech Concerto #6 Investment Process December 2008
Biotech Concerto #6 Investment Process December 2008 Index Biotech Investment Characteristics Investment Policy Investment Team Scientific Advisory Board Deal Flow Attrition Rate From Screening to Decision
More informationProgram in Intellectual Property Management: From the Lab to the Market
Program in Intellectual Property Management: From the Lab to the Market Friday and Saturday, October 17 & 18, 2008 Nanjing University Nanjing, China Organizers: Nanjing University University of Wisconsin
More informationWORLD ANGEL INVESTMENT SUMMIT
2018 WORLD ANGEL INVESTMENT SUMMIT TORONTO, ON SEPTEMBER 25-27, 2018 ANGEL GROUP PARTNERSHIP OPPORTUNITIES The Flagship Event for the Global Angel Investor Community Event Details Date: September 25-27,
More informationLife Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack
C5 Business Information in a Global Context Life Sciences CONFERENCE SERIES LIFE SCIENCES IP PORTFOLIO Business Development Pack C5 GROUPS LIFE SCIENCES EVENTS Pharmaceuticals, biotechnology, diagnostics,
More information6 TH CHINA INVESTMENT CONFERENCE
6 TH CHINA INVESTMENT CONFERENCE 207 CFA Society Beijing. All rights reserved. 2 August 207 China World Hotel Beijing, China Hosted by CFA Society Beijing SUPPORTER OPPORTUNITIES EVENT OVERVIEW Our flagship
More informationFortis to acquire strategic stake in Parkway Holdings, Singapore
PRESS RELEASE Fortis to acquire strategic stake in Parkway Holdings, Singapore Landmark cross border deal in Healthcare sector out of India Move will establish Fortis as Asia s largest hospital network
More informationHuge success for Everbright Investment Conference 2017 in Hong Kong as top minds gather to discuss new megatrends in finance and investment
Press Release Huge success for Everbright Investment Conference 2017 in Hong Kong as top minds gather to discuss new megatrends in finance and investment 26 October 2017, Hong Kong "Everbright Investment
More informationTechnology transfer and development: implications of four case studies Session 2
Technology transfer and development: implications of four case studies Session 2 Short courses for Permanent Missions in Geneva Monday, 15 December 2014 Michael Lim Policy Review Section Division on Technology
More informationThe Academy of Sciences of Hong Kong hosts The 2 nd Science and Technology Innovation Summit
Media release For Immediate release The Academy of Sciences of Hong Kong hosts The 2 nd Science and Technology Innovation Summit Spearheading discussions on bio-medicine and smart materials research development
More information2018 IIF ANNUAL MEMBERSHIP MEETING
2018 IIF ANNUAL MEMBERSHIP MEETING October 12-13, 2018 Grand Hyatt Nusa Dua, Bali, Indonesia PRELIMINARY AGENDA *Subject to change* FRIDAY, OCTOBER 12 7:30 am 8:30 am REGISTRATION AND REFRESHMENTS 8:30
More informationGLP CHINA LEADERSHIP TRANSITION
For Immediate Release GLP CHINA LEADERSHIP TRANSITION Teresa Zhuge and Victor Mok promoted from within the China business to serve as Co-Presidents Dual leadership structure allows GLP to focus on strengthening
More information2014 FOCUS RESEARCH ANNUAL CONFERENCE
2014 FOCUS RESEARCH ANNUAL CONFERENCE October 8 9, 2014 Hosted by Asset Management 50 South La Salle Street 6th Floor Chicago WEDNESDAY, OCTOBER 8th 7:30 am 8:00 am Breakfast 8:00 am 8:15 am Welcome and
More information8th Annual INSEAD Asian Private Equity and Venture Capital Conference
The INSEAD Private Equity Club cordially invites you to the 8th Annual INSEAD Asian Private Equity and Venture Capital Conference Date: Friday 4 November, 2016 Time: 12pm - 7pm SGT Venue: Asia Campus 1
More informationMETRO FINANCE AND DBS BANK (HONG KONG) PRESENT: "HONG KONG - ASEAN SUMMIT 2016" *** Highlight New Opportunities by ASEAN Economic Community
News Release METRO FINANCE AND DBS BANK (HONG KONG) PRESENT: "HONG KONG - ASEAN SUMMIT 2016" *** Highlight New Opportunities by ASEAN Economic Community Hong Kong, 29 August 2016 - ASEAN Summit 2016, organised
More informationVictorious warriors win first and then go to war, while defeated warriors go to war first and then seek to win - Sun Tzu
2 0 1 6 In the backdrop of ever increasing competition, and complex global market conditions, businesses are facing renewed obstacles from growing and succeeding. Thus, STRATEGY becomes an integral component
More informationPress Release For Immediate Release
Press Release For Immediate Release The Academy of Sciences of Hong Kong hosts the first Science and Technology Innovation Summit Scientists and leaders of other sectors discuss and debate on the role
More informationInvestor s Meeting. Managed by. May 12, Estancia La Jolla Hotel & Spa
Investor s Meeting Managed by May 12, 2009 Estancia La Jolla Hotel & Spa Lead Sponsor and Host: Meet the innovators and companies who are defining the convergence of wireless and biopharmaceuticals, medical
More informationCeQur establishes Wales subsidiary
FOR IMMEDIATE RELEASE CeQur establishes Wales subsidiary -- Arthurian Life Sciences investment helps bring to market world s first three-day simple insulin infusion device for type 2 diabetes -- LUCERNE,
More informationDriving profitable growth in Greater China. Andy Ho Chief Market Leader Greater China
Driving profitable growth in Greater China Andy Ho Chief Market Leader Greater China Key takeaways China HealthTech market is the 2 nd largest globally and exhibits continued robust growth with significant
More informationGuidelines to Promote National Integrated Circuit Industry Development : Unofficial Translation
Guidelines to Promote National Integrated Circuit Industry Development : Unofficial Translation Ministry of Industry and Information Technology National Development and Reform Commission Ministry of Finance
More informationContinuing the discussions at the Asia-Pacific Business Forum held at Cyberport just right
For Immediate Release Internet Economy Summit 2018 Unlocked Insights on Digital Innovation Global leaders from start-ups to internet giants shared views on the future of business Hong Kong, 12 April, 2018
More informationPergamon Corporation CONFRENCE
Pergamon Corporation CONFRENCE IP Stategy, Patent Portfolio Development and InnovationEarn CLE Dissecting the evolving spectrum of intellectual property rights, and licensing to foster innovation May 23-24,
More informationThe Investigation of Bio-medical Science and Technology Innovation Service Platform in Guangzhou
The Investigation of Bio-medical Science and Technology Innovation Service Platform in Guangzhou Hong-Ming HOU 1,a,*, Hong-Shen PANG 1,b,*, Yi-Bing SONG 1, Hai-Yun XU 2, Jing-Hui-Ni XIONG 3, Xiao-Yan JIANG
More informationDigitising Manufacturing in the G20 Initiatives, Best Practices and Policy Approaches March 2017, Berlin
Start Invitation Einladung Programme ProgrammInformation Informationen Anfahrt Digitising Manufacturing in the G20 Initiatives, Best Practices and Policy Approaches 16 17 March 2017, Berlin Invitation
More informationMetro Finance and DBS Bank present: Hong Kong ASEAN Summit 2015 The New ASEAN Economy under the One Belt, One Road
Press Release For Immediate Release Metro Finance and DBS Bank present: Hong Kong ASEAN Summit 2015 The New ASEAN Economy under the One Belt, One Road 14 September 2015 As part of China s wider economic
More informationThe Association s high-level visit to Hong Kong in April 2018
The Association s high-level visit to Hong Kong in April 2018 In April 2018, Kimberly N Ellison-Taylor, Chairman, Association of International Certified Professional Accountants & Immediate Past Chairman,
More informationAGENDA THE NATION S PREMIER DEAL FLOW & BUSINESS CONFERENCE #DEALNATION
2018 ACGLA B U S I N E S S CONFERENCE POCKET GUIDE AGENDA THE NATION S PREMIER DEAL FLOW & BUSINESS CONFERENCE #DEALNATION AGENDA SPONSORED BY: SEPTEMBER 25-26, 2018 TUESDAY, SEPTEMBER 25 9:00AM 2:30PM
More informationDigital Medical Device Innovation: A Prescription for Business and IT Success
10 September 2018 Digital Medical Device Innovation: A Prescription for Business and IT Success A Digital Transformation is reshaping healthcare. New technology, mobility, and advancements in computing
More informationDammika Peiris, Senior Pharmacovigilance Manager and Head of Chugai Pharma Europe
Key Speakers: Paul Dolin, Head of Pharmacoepidemiology, Takeda Pharmaceuticals Dr. Katrin Freund, Project Excellence Manager (Social Media) Drug Safety & Epidemiology, Novartis Pharma GmbH Dr. Heike Schoepper,
More informationEXPO. October 15-17, 2014 ADVANCE PROGRAM HEALTHCARE SUPPLY CHAIN. Register online at. JW Marriott Washington, DC
ADVANCE PROGRAM Register online at www.supplychainassociation.org/expo or www.hiscionline.org/expo 201 4 HEALTHCARE SUPPLY CHAIN EXPO C O - H O S T E D B Y H S C A A N D H I S C I October 15-17, 2014 JW
More informationProspect Report of IT Application in Asia
Prospect Report of IT Application in Asia The 3 rd Forum On City Informatization in the Asia-Pacific Region The 3rd Forum on City Informatization in the Asia-Pacific Region (CIAPR III Shanghai 2002) Sponsors:
More informationOverview + Sponsorship Opportunities. Advancing LGBT+ diversity in corporate governance
Overview + Sponsorship Opportunities Advancing LGBT+ diversity in corporate governance Our Purpose: Ensuring LGBT+ diversity is central in conversations about board representation and policy. Quorum is
More informationTechnology Transfer for Small and Medium Sized Enterprises
International Conference on Technology Transfer for Small and Medium Sized Enterprises Organized by the International Intellectual Property Institute (IIPI) Sponsored by the World Intellectual Property
More informationCompeting by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health
Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health March 8, 2012 Boston Geneva Mumbai San Francisco Seattle Washington Contents 1. Plenary Session
More informationWORLD ANGEL INVESTMENT SUMMIT
2018 WORLD ANGEL INVESTMENT SUMMIT TORONTO, ON SEPTEMBER 25-27, 2018 ANGEL GROUP PARTNERSHIP OPPORTUNITIES The Flagship Event for the Global Angel Investor Community Event Details Date: September 25-27,
More informationTechnology Leadership Course Descriptions
ENG BE 700 A1 Advanced Biomedical Design and Development (two semesters, eight credits) Significant advances in medical technology require a profound understanding of clinical needs, the engineering skills
More informationChaired by: Keith Gregg, MBA, CLP, Chairman, JRG VENTURES and Entrepreneur-in- Residence for Health Technology, NASHVILLE ENTREPRENEUR CENTER
Wednesday, September 19, Forum: Technology and New Healthcare Business Models With the Supreme Court decision, healthcare systems must look into blossoming technology innovations to improve patient care,
More informationTHE СONCEPT OF THE MOSCOW INTERNATIONAL FORUM FOR INNOVATIVE DEVELOPMENT OPEN INNOVATIONS * October 31 November 2, * as of April
THE СONCEPT OF THE MOSCOW INTERNATIONAL FORUM FOR INNOVATIVE DEVELOPMENT OPEN INNOVATIONS * October 31 November 2, 2013 * as of April 2013 1 The Key Theme of the Forum 2013 Disruption and Innovation: Game
More informationImminent Transformations in Health
Imminent Transformations in Health Written By: Dr. Hugh Rashid, Co-Chair Technology & Innovation Committee American Chamber of Commerce, Shanghai AmCham Shanghai s Technology and Innovation Committee and
More information2016 MEDEC MedTech Conference April 26 and 27, 2016 Transformation through Innovation & Collaboration FINAL AGENDA
Tuesday, April 26, 2016 2016 MEDEC MedTech Conference April 26 and 27, 2016 Transformation through Innovation & Collaboration FINAL AGENDA TIME SESSION SPEAKER DESCRIPTION 7:30 8:30 Registration & Breakfast
More informationIR Magazine Awards & Conference Greater China. Past attendee list
IR Magazine Awards & Conference Greater China Past attendee list Job title, Executive and Co-CEO, IR Deputy Manager, Asia Pacific equity strategist and global emerging markets strategist co-head of global
More informationTHE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES
THE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES Join us for a very special program co-hosted the HBS Alumni of Boston (HBSAB), The Harvard Stem Cell Institute (HSCI), and the Harvard NeuroDiscovery
More informationBig Data & Analytics Innovation Summit
Big Data & Analytics Innovation Summit November 22 & 23 2017 Beijing Strategize Your Data Capabilities To Maximize Business Performance ABOUT THE EVENT Overview November 22 & 23, 2017 Swissotel Beijing,
More informationHFMA January CFO Forum
HFMA January CFO Forum January 26, 2018 St. Mark s Hospital Education Auditorium 1200 E. 3900 S. Salt Lake City, Utah 7.0 CPE hours 7:30 8:00 a.m. Continental Breakfast 8:00 8:15 a.m. Opening and Chapter
More informationInvitation to Hong Kong and Mainland China Capital Market Forum "SZ-HK Stock Connect Insights"
Invitation to Hong Kong and Mainland China Capital Market Forum Dear distinguished guest, We are honored to invite you to participate in the Mainland China and Hong Kong Capital Market Forum, which will
More informationThe Complexities of Mixed Use
The Complexities of Mixed Use 2:30 pm 5:00 pm Thursday, October 15, 2015 Piper Auditorium, Gund Hall MDes Real Estate & the Built Environment Harvard University Graduate School of Design 48 Quincy Street,
More informationWorkshop. Enhancing Innovation: Collaborative Mechanisms For Intellectual Property Management in the Life Sciences
Workshop Enhancing Innovation: Collaborative Mechanisms For Intellectual Property Management in the Life Sciences WORKSHOP PROGRAMME 4-5 May 2009 OECD Headquarters 2, Rue Andre-Pascal, 75016 Paris For
More information